Portal de Periódicos da CAPES

Stability of linear and macrocyclic gadolinium based contrast agents

2007; Wiley; Volume: 80; Issue: 955 Linguagem: Inglês

10.1259/bjr/17326033

1748-880X

Heribert Schmitt‐Willich,

Medical Imaging Techniques and Applications

CorrespondenceStability of linear and macrocyclic gadolinium based contrast agentsH Schmitt-WillichH Schmitt-WillichPrincipal Scientist GDD MedChem 6 Bayer Schering Pharma AG Muellerstr. 170-178 Berlin 10551 Germany. E-mail: Published Online:28 Jan 2014https://doi.org/10.1259/bjr/17326033SectionsPDF/EPUBFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail About References 1 Morcos SK. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 2007;80:73–6. Link ISI, Google Scholar2 Schmitt‐Willich H, Brehm M, Ewers CL, Michl G, Mueller‐Fahrnow A, Petrov O, et al. Synthesis and physicochemical characterization of a new gadolinium chelate: the liver-specific magnetic resonance imaging contrast agent Gd-EOB-DTPA. Inorg Chem 1999;38:1134–44. Crossref Medline ISI, Google Scholar3 Idee JM, Port M, Raynal I, et al. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Fundam Clin Pharmacol 2006;20:563–76. Crossref Medline ISI, Google Scholar4 Shellock FG, Parker JR, Pirovano G, et al. Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine. J Magn Reson Imaging 2006;24:1378–85. Crossref Medline ISI, Google Scholar5 Wedeking P, Kumar K, Tweedle MF. Dissociation of gadolinium chelates in mice: relationship to chemical characteristics. Magn Reson Imaging 1992;10:641–8. Crossref Medline ISI, Google Scholar6 Pulukkody KP, Norman TJ, Parker D, et al. Synthesis of charged and uncharged complexes of gadolinium and yttrium with cyclic polyazaphosphinic acid ligands for in-vivo applications. J Chem Soc Perkin Trans 2 1993;605–620. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited byEffect of gadopentetate dimeglumine on bone growth in zebrafish caudal finsToxicology Letters, Vol. 374Clinical Significance of Liver MR ImagingMagnetic Resonance in Medical SciencesGadolinium deposition in the brain is related to various contrast agents: a matched case–control studyClinical Radiology, Vol. 77, No. 4Manganese(II) EOB-Pyclen Diacetate for Liver-Specific MRI11 February 2022 | ACS Applied Bio Materials, Vol. 5, No. 2Contrast agents for MRI and side effectsMagnetic levitation assisted biofabrication, culture, and manipulation of 3D cellular structures using a ring magnet based setup5 October 2021 | Biotechnology and Bioengineering, Vol. 118, No. 12Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging20 March 2021 | Abdominal Radiology, Vol. 46, No. 8Nephrogenic Systemic Fibrosis as a Complication after Gadolinium-Containing Contrast Agents: A Rapid Review15 March 2021 | International Journal of Environmental Research and Public Health, Vol. 18, No. 6Chemistry, Physicochemical Properties and Pharmacokinetics of Gadolinium-Based Contrast Agents25 August 2021Gadolinium-Based Contrast Agent Toxicity and Accumulation25 August 2021Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles11 October 2020 | Histochemistry and Cell Biology, Vol. 155, No. 1Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration27 February 2020 | American Journal of Neuroradiology, Vol. 41, No. 3Gadolinium chloride promotes proliferation of HEK293 human embryonic kidney cells by activating EGFR/PI3K/Akt and MAPK pathways8 July 2019 | BioMetals, Vol. 32, No. 4Safety of gadobutrol: results of a non-interventional study of 3710 patients, including 404 children25 September 2018 | Acta Radiologica, Vol. 60, No. 7Erhöhte Signalintensitäten und Gadolinium-Werte im Gehirn nach Gabe Gadolinium-haltiger MR-Kontrastmittel18 March 2019 | Der Radiologe, Vol. 59, No. 4Are radio-contrast agents commonly used in discography toxic to the intact intervertebral disc tissue cells?11 September 2018 | Basic & Clinical Pharmacology & Toxicology, Vol. 124, No. 2Contrast Agents in Cardiovascular Magnetic Resonance Imaging1 February 2019Biofabrication of in situ Self Assembled 3D Cell Cultures in a Weightlessness Environment Generated using Magnetic Levitation8 May 2018 | Scientific Reports, Vol. 8, No. 1Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium ChelatesRadiology, Vol. 289, No. 2Oxygen plasma-fragmented KMnF 3 nanoparticle benefits contrast enhancement for MRI of a patient-derived tumor xenograft model29 June 2018 | Nanotechnology, Vol. 29, No. 36Gadolinium Accumulation in the Deep Cerebellar Nuclei and Globus Pallidus After Exposure to Linear but Not Macrocyclic Gadolinium-Based Contrast Agents in a Retrospective Pig Study With High Similarity to Clinical ConditionsInvestigative Radiology, Vol. 53, No. 5Pediatric BrainInvestigative Radiology, Vol. 53, No. 4Contrast Agents for MR ImagingMagnetic Resonance Imaging Clinics of North America, Vol. 25, No. 4Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model12 January 2017 | European Radiology, Vol. 27, No. 8Contrast Agent–Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted ImagesInvestigative Radiology, Vol. 52, No. 7Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast AgentsInvestigative Radiology, Vol. 52, No. 6Safety of GadobutrolInvestigative Radiology, Vol. 51, No. 9X-Ray, MRI, and Ultrasound Agents: Basic Principles4 February 2016National Institutes of Health Perspective on Reports of Gadolinium Deposition in the BrainJournal of the American College of Radiology, Vol. 13, No. 3Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus GadobutrolAmerican Journal of Roentgenology, Vol. 206, No. 225 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives25 January 2016 | Advances in Therapy, Vol. 33, No. 1Preliminary experience with intravenous gadoxetate disodium as a craniospinal MR contrast agentEuropean Journal of Radiology, Vol. 84, No. 12Nephrogenic Systemic Fibrosis Risk After Liver Magnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal ImpairmentInvestigative Radiology, Vol. 50, No. 6Interference of gadolinium-based contrast agents on colorimetric calcium assaysClinical Biochemistry, Vol. 47, No. 7-8Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumorJournal of Controlled Release, Vol. 167, No. 1X-ray-Computed Tomography Contrast Agents5 December 2012 | Chemical Reviews, Vol. 113, No. 3Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1mmolGd/kg body weight in a clinical settingEuropean Journal of Radiology, Vol. 82, No. 1Safety and Efficacy of Gadobutrol-enhanced Mri in Patients Aged under 2 Years–-a Single-center, Observational Study6 February 2013 | Magnetic Resonance Insights, Vol. 6Diagnostic Imaging Agents5 October 2012MRI contrast agents: Basic chemistry and safety22 October 2012 | Journal of Magnetic Resonance Imaging, Vol. 36, No. 5Toxicological Safety Evaluation of GadobutrolInvestigative Radiology, Vol. 47, No. 11Nephrogenic Systemic Fibrosis11 November 2011Convenient grafting through approach for the preparation of stealth polymeric blood pool magnetic resonance imaging contrast agents20 June 2011 | Journal of Polymer Science Part A: Polymer Chemistry, Vol. 49, No. 17Evaluation of the Effect of Two Gadolinium-Containing Contrast-Enhancing Agents, Gadobutrol and Gadoxetate Disodium, on Colorimetric Calcium Determinations in Serum and PlasmaInvestigative Radiology, Vol. 46, No. 6Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?17 September 2010 | European Radiology, Vol. 21, No. 3Diamagnetically trapped arrays of living cells above micromagnetsLab on a Chip, Vol. 11, No. 18Prevalence of acute adverse reactions to gadobutrol—A highly concentrated macrocyclic gadolinium chelate: Review of 14,299 patients from observational trialsEuropean Journal of Radiology, Vol. 74, No. 3Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: Comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 TJournal of Magnetic Resonance Imaging, Vol. 31, No. 3Pathophysiology of nephrogenic systemic fibrosis: A review of experimental dataWorld Journal of Radiology, Vol. 2, No. 11Role of thermodynamic and kinetic parameters in gadolinium chelate stabilityJournal of Magnetic Resonance Imaging, Vol. 30, No. 6Gadolinium-based contrast agents and NSF: Evidence from animal experienceJournal of Magnetic Resonance Imaging, Vol. 30, No. 6Re: Chemical Structure and Stability of Gadolinium ChelatesRadioGraphics, Vol. 29, No. 7Nephrogenic Systemic Fibrosis and Its Impact on Abdominal ImagingRadioGraphics, Vol. 29, No. 6Involvement of Gadolinium Chelates in the Mechanism of Nephrogenic Systemic Fibrosis: An UpdateRadiologic Clinics of North America, Vol. 47, No. 5Evaluating the role of zinc in the occurrence of fibrosis of the skin: A preclinical studyJournal of Magnetic Resonance Imaging, Vol. 30, No. 2Long-term retention of gadolinium in the skin of rodents following the administration of gadolinium-based contrast agents24 January 2009 | European Radiology, Vol. 19, No. 6Comparison of 1.0 M Gadobutrol and 0.5 M Gadopentetate Dimeglumine-Enhanced Magnetic Resonance Imaging in Five Hundred Seventy-Two Patients With Known or Suspected Liver LesionsInvestigative Radiology, Vol. 44, No. 3Design and function of metal complexes as contrast agents in MRIQuality Initiatives MR Imaging in Patients at Risk for Developing Nephrogenic Systemic Fibrosis: Protocols, Practices, and Imaging Techniques to Maximize Patient SafetyRadioGraphics, Vol. 29, No. 1Comparison of 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine-enhanced MRI in 471 patients with known or suspected renal lesions: results of a multicenter, single-blind, interindividual, randomized clinical phase III trial8 July 2008 | European Radiology, Vol. 18, No. 11Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions11 June 2008 | European Radiology, Vol. 18, No. 10Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review15 March 2008 | BioMetals, Vol. 21, No. 4Nephrogenic systemic fibrosis and the role of gadolinium contrast mediaJournal of Medical Imaging and Radiation Oncology, Vol. 52, No. 4Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: The role of excess ligand1 January 2008 | Journal of Magnetic Resonance Imaging, Vol. 27, No. 5Stability of gadolinium chelates and their biological consequences: new data and some commentsM PORT, J-M IDEE, C MEDINA, A DENCAUSSE and C COROT5 March 2014 | The British Journal of Radiology, Vol. 81, No. 963Nephrogenic Systemic Fibrosis21 January 2008 | Imaging Decisions MRI, Vol. 11, No. 4Summary of Safety of Vasovist® at 0.03 mmol/kg Body Weight Dose — Clinical DataGadolinium(iii) complexes as MRI contrast agents: ligand design and properties of the complexesDalton Transactions, Vol. 14, No. 23 Volume 80, Issue 955July 2007Pages: 503-e154 © The British Institute of Radiology History ReceivedApril 25,2007AcceptedMay 13,2007Published onlineJanuary 28,2014 Metrics Download PDF